PARTICIPANTS WITH ADVANCED SOLID TUMOR MALIGNANCIES
Clinical trials for PARTICIPANTS WITH ADVANCED SOLID TUMOR MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new PARTICIPANTS WITH ADVANCED SOLID TUMOR MALIGNANCIES trials appear
Sign up with your email to follow new studies for PARTICIPANTS WITH ADVANCED SOLID TUMOR MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug VBC103 targets tough cancers in early trial
Disease control Recruiting nowThis study tests a new drug called VBC103 in people with advanced solid tumors that have not responded to standard treatments. VBC103 is designed to target two proteins on cancer cells to deliver a toxic payload. The trial will enroll 255 participants to find the safest dose and …
Matched conditions: PARTICIPANTS WITH ADVANCED SOLID TUMOR MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: VelaVigo Bio Inc • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug VBC101 targets tough cancers in early trial
Disease control Recruiting nowThis early-stage trial tests a new drug called VBC101 in people with advanced solid tumors that have stopped responding to standard treatments. The drug is designed to attach to two cancer-related targets (EGFR and cMET) and deliver a toxic payload directly to cancer cells. The s…
Matched conditions: PARTICIPANTS WITH ADVANCED SOLID TUMOR MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: VelaVigo Bio Inc • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC